You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 6, June 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (87)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Psychiatry, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Differential Hippocampal Expression of Glutamic Acid Decarboxylase 65 and 67 Messenger RNA in Bipolar Disorder and Schizophrenia

Stephan Heckers, MD; David Stone, PhD; John Walsh, MA; John Shick; Pamposh Koul; Francine M. Benes, MD, PhD

Arch Gen Psychiatry. 2002;59:521-529.

Background  Expression of messenger RNA (mRNA) for the {gamma}-aminobutyric acid (GABA)–synthesizing enzyme, glutamic acid decarboxylase (GAD), in the prefrontal cortex and the number of GABAergic neurons in the hippocampus are reduced in schizophrenia and bipolar disorder. We tested the hypothesis that the expression of the 2 isoforms, one 65 kd (GAD65) and the other 67 kd (GAD67), is differentially affected in the hippocampus in schizophrenia and bipolar disorder.

Methods  Hippocampal sections from 15 subjects in 3 groups (control subjects and subjects with schizophrenia and bipolar disorder) were studied using an in situ hybridization protocol with sulfur 35–labeled complementary riboprobes for GAD65 and GAD67 mRNA. Emulsion-dipped slides were analyzed for the density of GAD mRNA–positive neurons in 4 sectors of the hippocampus and for the cellular expression level of both GAD mRNAs.

Results  The density of GAD65 and GAD67 mRNA–positive neurons was decreased by 45% and 43%, respectively, in subjects with bipolar disorder, but only 14% and 4%, respectively, in subjects with schizophrenia. The decreased density of GAD65 mRNA–positive neurons in subjects with bipolar disorder was significant in sectors CA2/3 and dentate gyrus, and that of GAD67 mRNA–positive neurons was significant in CA4, but not other hippocampal sectors. Cellular GAD65 mRNA expression was significantly decreased in subjects with bipolar disorder, particularly in CA4, but not in schizophrenic subjects. Cellular GAD67 mRNA expression was normal in both groups.

Conclusion  We have found a region-specific deficit of GAD65 and GAD67 mRNA expression in bipolar disorder.


From the Laboratory of Structural Neuroscience, McLean Hospital, Belmont, Mass (Drs Heckers, Stone, and Benes; Messrs Walsh and Shick; and Ms Koul), and Department of Psychiatry (Drs Heckers and Benes) and Program of Neuroscience (Dr Benes), Harvard Medical School, Boston, Mass.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Loss of Parvalbumin-Containing Interneurons Is Associated with Diminished Oscillatory Activity in an Animal Model of Schizophrenia
Lodge et al.
J. Neurosci. 2009;29:2344-2354.
ABSTRACT | FULL TEXT  

Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars
Benes et al.
Proc. Natl. Acad. Sci. USA 2008;105:20935-20940.
ABSTRACT | FULL TEXT  

Altered Expression of Genes Involved in GABAergic Transmission and Neuromodulation of Granule Cell Activity in the Cerebellum of Schizophrenia Patients
Bullock et al.
Am. J. Psychiatry 2008;165:1594-1603.
ABSTRACT | FULL TEXT  

Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase
Behrens et al.
Science 2007;318:1645-1647.
ABSTRACT | FULL TEXT  

Prefrontal Dysfunction in Schizophrenia Involves Mixed-Lineage Leukemia 1-Regulated Histone Methylation at GABAergic Gene Promoters
Huang et al.
J. Neurosci. 2007;27:11254-11262.
ABSTRACT | FULL TEXT  

Regulation of synaptic plasticity in a schizophrenia model
Gisabella et al.
Proc. Natl. Acad. Sci. USA 2005;102:13301-13306.
ABSTRACT | FULL TEXT  

Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia
Dong et al.
Proc. Natl. Acad. Sci. USA 2005;102:12578-12583.
ABSTRACT | FULL TEXT  

Reelin promoter hypermethylation in schizophrenia
Grayson et al.
Proc. Natl. Acad. Sci. USA 2005;102:9341-9346.
ABSTRACT | FULL TEXT  

Neural Cell Adhesion Molecule-Secreting Transgenic Mice Display Abnormalities in GABAergic Interneurons and Alterations in Behavior
Pillai-Nair et al.
J. Neurosci. 2005;25:4659-4671.
ABSTRACT | FULL TEXT  

Density of Glutamic Acid Decarboxylase 67 Messenger RNA-Containing Neurons That Express the N-Methyl-D-Aspartate Receptor Subunit NR2A in the Anterior Cingulate Cortex in Schizophrenia and Bipolar Disorder
Woo et al.
Arch Gen Psychiatry 2004;61:649-657.
ABSTRACT | FULL TEXT  

Molecular Evidence for Mitochondrial Dysfunction in Bipolar Disorder
Konradi et al.
Arch Gen Psychiatry 2004;61:300-308.
ABSTRACT | FULL TEXT  

DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains
Veldic et al.
Proc. Natl. Acad. Sci. USA 2004;101:348-353.
ABSTRACT | FULL TEXT  

Amygdala and Hippocampal Volumes in Adolescents and Adults With Bipolar Disorder
Blumberg et al.
Arch Gen Psychiatry 2003;60:1201-1208.
ABSTRACT | FULL TEXT  

Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia
Hashimoto et al.
J. Neurosci. 2003;23:6315-6326.
ABSTRACT | FULL TEXT  

Epigenetic Downregulation of GABAergic Function in Schizophrenia: Potential for Pharmacological Intervention?
Costa et al.
Mol. Interv. 2003;3:220-229.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.